Noninvasive fetal genomic, methylomic, and transcriptomic analyses using maternal plasma and clinical implications

Trends in Molecular Medicine

Volumn 21, Issue 2, 2015, Pages 98-108

  Wong, Ada I C ^a   Lo, Y M Dennis ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cell free DNA; Fetal epigenome; Fetal transcriptome; Massively parallel sequencing; Noninvasive prenatal diagnosis

Indexed keywords

ANEUPLOIDY; BIOMICS; DIAGNOSIS; EPIGENETICS; GENE SEQUENCE; GENETIC ANALYSIS; GENOME; GENOMICS; HUMAN; MATERNAL PLASMA; METHYLOMIC; NON INVASIVE PROCEDURE; NONINVASIVE PRENATAL TRANSCRIPTOMIC ANALYSIS; PLASMA EPIGENOMICS; REVIEW; SIZE BASED DIAGNOSTICS; TRANSCRIPTOMICS; BLOOD; DNA METHYLATION; FEMALE; FETAL DISEASES; GENETICS; METABOLISM; PREGNANCY; PRENATAL DIAGNOSIS;

TRANSCRIPTOME;

DNA METHYLATION; FEMALE; FETAL DISEASES; GENOMICS; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; TRANSCRIPTOME;

EID: 84922887929     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2014.12.006     Document Type: Review

References (65)

1. Lo Y.M.D., et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997, 350:485-487.
2. Chan K.C.A., et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin. Chem. 2004, 50:88-92.
3. Li Y., et al. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin. Chem. 2004, 50:1002-1011.
4. Lo Y.M.D., et al. Rapid clearance of fetal DNA from maternal plasma. Am. J. Hum. Genet. 1999, 64:218-224.
5. Chan K.C.A., et al. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin. Chem. 2006, 52:2211-2218.
6. Chim S.S.C., et al. Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. Clin. Chem. 2008, 54:500-511.
7. Chiu R.W.K., et al. Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin. Chem. 2002, 48:778-780.
8. Chiu R.W.K., et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:20458-20463.
9. Sparks A.B., et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat. Diagn. 2012, 32:3-9.
10. Zimmermann B., et al. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci. Prenat. Diagn. 2012, 32:1233-1241.
11. Yu S.C., et al. Noninvasive prenatal molecular karyotyping from maternal plasma. PLoS ONE 2013, 8:e60968.
12. Lam K.W., et al. Noninvasive prenatal diagnosis of monogenic diseases by targeted massively parallel sequencing of maternal plasma: application to beta-thalassemia. Clin. Chem. 2012, 58:1467-1475.
13. New M.I., et al. Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma. J. Clin. Endocrinol. Metab. 2014, 99:E1022-E1030.
14. Lun F.M.F., et al. Noninvasive prenatal methylomic analysis by genomewide bisulfite sequencing of maternal plasma DNA. Clin. Chem. 2013, 59:1583-1594.
15. Tsui N.B.Y., et al. Maternal plasma RNA sequencing for genome-wide transcriptomic profiling and identification of pregnancy-associated transcripts. Clin. Chem. 2014, 60:954-962.
16. Tabor A., Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn. Ther. 2010, 27:1-7.
17. Driscoll D.A., Gross S.J. Screening for fetal aneuploidy and neural tube defects. Genet. Med. 2009, 11:818-821.
18. Lo Y.M.D., et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:13116-13121.
19. Fan H.C., Quake S.R. Detection of aneuploidy with digital polymerase chain reaction. Anal. Chem. 2007, 79:7576-7579.
20. Fan H.C., et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:16266-16271.
21. Liao G.J.W., et al. Targeted massively parallel sequencing of maternal plasma DNA permits efficient and unbiased detection of fetal alleles. Clin. Chem. 2011, 57:92-101.
22. Nicolaides K.H., et al. Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. Prenat. Diagn. 2013, 33:575-579.
23. Liao G.J.W., et al. Noninvasive prenatal diagnosis of fetal trisomy 21 by allelic ratio analysis using targeted massively parallel sequencing of maternal plasma DNA. PLoS ONE 2012, 7:e38154.
24. Juneau K., et al. Microarray-based cell-free DNA analysis improves noninvasive prenatal testing. Fetal Diagn. Ther. 2014, 36:282-286.
25. Sparks A.B., et al. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am. J. Obstet. Gynecol. 2012, 206:319.e1-9.
26. Chiu R.W.K., et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011, 342:c7401.
27. Ehrich M., et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am. J. Obstet. Gynecol. 2011, 204:205.e1-11.
28. Bianchi D.W., et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet. Gynecol. 2012, 119:890-901.
29. Palomaki G.E., et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet. Med. 2011, 13:913-920.
30. Norton M.E., et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am. J. Obstet. Gynecol. 2012, 207:137.e1-8.
31. Ashoor G., et al. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012, 206. 322.e1-5.
32. Gil M.M., et al. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis. Fetal Diagn. Ther. 2014, 35:156-173.
33. Chandrasekharan S., et al. Noninvasive prenatal testing goes global. Sci. Transl. Med. 2014, 6:231fs215.
34. Peters D., et al. Noninvasive prenatal diagnosis of a fetal microdeletion syndrome. N. Engl. J. Med. 2011, 365:1847-1848.
35. Jensen T.J., et al. Detection of microdeletion 22q11.2 in a fetus by next-generation sequencing of maternal plasma. Clin. Chem. 2012, 58:1148-1151.
36. Srinivasan A., et al. Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am. J. Hum. Genet. 2013, 92:167-176.
37. Rabinowitz M., et al. Noninvasive cell-free DNA-based prenatal detection of microdeletions using single nucleotide polymorphism-targeted sequencing. Obstet. Gynecol. 2014, 123(Suppl. 1):167S.
38. Lo Y.M.D., et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci. Transl. Med. 2010, 2:61ra91.
39. Fan H.C., et al. Non-invasive prenatal measurement of the fetal genome. Nature 2012, 487:320-324.
40. Kitzman J.O., et al. Noninvasive whole-genome sequencing of a human fetus. Sci. Transl. Med. 2012, 4:137ra176.
41. Conrad D.F., et al. Variation in genome-wide mutation rates within and between human families. Nat. Genet. 2011, 43:712-714.
42. Yu S.C., et al. High-resolution profiling of fetal DNA clearance from maternal plasma by massively parallel sequencing. Clin. Chem. 2013, 59:1228-1237.
43. New M.I., et al. An update on prenatal diagnosis and treatment of congenital adrenal hyperplasia. Semin. Reprod. Med. 2012, 30:396-399.
44. Ma D., et al. Haplotype-based approach for noninvasive prenatal diagnosis of congenital adrenal hyperplasia by maternal plasma DNA sequencing. Gene 2014, 544:252-258.
45. Yu S.C., et al. Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:8583-8588.
46. Canick J.A., et al. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. Prenat. Diagn. 2013, 33:667-674.
47. Lo Y.M.D., et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am. J. Hum. Genet. 1998, 62:768-775.
48. Lun F.M.F., et al. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin. Chem. 2008, 54:1664-1672.
49. Jiang P., et al. FetalQuant: deducing fractional fetal DNA concentration from massively parallel sequencing of DNA in maternal plasma. Bioinformatics 2012, 28:2883-2890.
50. Chim S.S.C., et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:14753-14758.
51. Tomizawa S., Sasaki H. Genomic imprinting and its relevance to congenital disease, infertility, molar pregnancy and induced pluripotent stem cell. J. Hum. Genet. 2012, 57:84-91.
52. Banister C.E., et al. Infant growth restriction is associated with distinct patterns of DNA methylation in human placentas. Epigenetics 2011, 6:920-927.
53. Poon L.L.M., et al. Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. Clin. Chem. 2002, 48:35-41.
54. Lister R., et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009, 462:315-322.
55. Kulis M., et al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat. Genet. 2012, 44:1236-1242.
56. Futscher B.W., et al. Role for DNA methylation in the control of cell type specific maspin expression. Nat. Genet. 2002, 31:175-179.
57. Rakyan V.K., et al. An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Res. 2008, 18:1518-1529.
58. Chavan-Gautam P., et al. Gestation-dependent changes in human placental global DNA methylation levels. Mol. Reprod. Dev. 2011, 78:150.
59. Jiang P., et al. Methy-Pipe: an integrated bioinformatics pipeline for whole genome bisulfite sequencing data analysis. PLoS ONE 2014, 9:e100360.
60. Poon L.L.M., et al. Presence of fetal RNA in maternal plasma. Clin. Chem. 2000, 46:1832-1834.
61. Ng E.K.O., et al. mRNA of placental origin is readily detectable in maternal plasma. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:4748-4753.
62. Ng E.K.O., et al. Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin. Chem. 2002, 48:1212-1217.
63. Koh W., et al. Noninvasive in vivo monitoring of tissue-specific global gene expression in humans. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:7361-7366.
64. Mazloom A.R., et al. Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma. Prenat. Diagn. 2013, 33:591-597.
65. Nicolaides K.H., et al. Assessment of fetal sex chromosome aneuploidy using directed cell-free DNA analysis. Fetal Diagn. Ther. 2014, 35:1-6.